Is Jenburkt Pharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Jenburkt Pharmaceuticals Ltd (524731.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Jenburkt Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Jenburkt Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Jenburkt Pharmaceuticals Ltd?

Muslim investors may consider investing in Jenburkt Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Jenburkt Pharmaceuticals Ltd classified as HALAL?

Musaffa determines the Shariah status of Jenburkt Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Jenburkt Pharmaceuticals Ltd updated?

The Shariah compliance status of Jenburkt Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Jenburkt Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Jenburkt Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Jenburkt Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Jenburkt Pharmaceuticals Ltd 524731.BO

₹1,200.00 ₹16.80 (1.42%) 1D

Last Updated: May 15, 12:00 AM·BSE

524731.BO Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: January 05, 2026

Report Source: 2026 2nd Quarter Report

Jenburkt Pharmaceuticals Ltd. Stock Analysis 524731.BO

India Health Care Nano Cap Report: Q2, 2026

Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products. The company is headquartered in Mumbai, Maharashtra and currently employs 779 full-time employees. The firm offers pharmaceutical products for various therapeutic areas, including analgesic and antipyretics, anthelmintics, anti-arthritics, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants/antacids, aphrodisiac, consumer products, muscle relaxants, neuropathic pain, nutraceuticals, and pain management. The firm's product brands include Allerzine tablets, Cartisafe forte MSM tablets, Eberjen Cream and SOL, ECOPROT powder, Frendacid suspension, Fundu tablets, Glajen-E capsules, GLUCOTROL tablets, Jenflam tablets, Lutriben cream, Ornel tablets, Pantazole tablets, Topcal-M Tablets, Powergesic, ZIX P Tablet, and others. The firm's manufacturing plant is in Sihor, Gujarat.

Key Statistics of Jenburkt Pharmaceuticals Ltd (524731.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹1,183.00₹1,213.00

Today's Open

₹1,183.20

Volume

311.00

P/E Ratio (TTM)

16.10

52 Week Range

₹944.00₹1,410.00

Market Cap

4.55B

Avg. Volume

2527.09

Dividend Yield

1.55%

Financial Metrics & Statements of Jenburkt Pharmaceuticals Ltd (524731.BO)

FAQ's for Jenburkt Pharmaceuticals Ltd (524731.BO)

According to Musaffa’s Shariah screening methodology, Jenburkt Pharmaceuticals Ltd (524731.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.